382 related articles for article (PubMed ID: 24419061)
1. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent.
Liu X; Chhipa RR; Nakano I; Dasgupta B
Mol Cancer Ther; 2014 Mar; 13(3):596-605. PubMed ID: 24419061
[TBL] [Abstract][Full Text] [Related]
2. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C.
Vucicevic L; Misirkic M; Janjetovic K; Harhaji-Trajkovic L; Prica M; Stevanovic D; Isenovic E; Sudar E; Sumarac-Dumanovic M; Micic D; Trajkovic V
Biochem Pharmacol; 2009 Jun; 77(11):1684-93. PubMed ID: 19428322
[TBL] [Abstract][Full Text] [Related]
5. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.
Vucicevic L; Misirkic M; Janjetovic K; Vilimanovich U; Sudar E; Isenovic E; Prica M; Harhaji-Trajkovic L; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V
Autophagy; 2011 Jan; 7(1):40-50. PubMed ID: 20980833
[TBL] [Abstract][Full Text] [Related]
6. Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway.
Zhao W; Peng F; Shu M; Liu H; Hou X; Wang X; Ye J; Zhao B; Wang K; Zhong C; Xue L; Gao M; Liu Y; Zhao S
Cell Physiol Biochem; 2017; 44(4):1381-1395. PubMed ID: 29186708
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
8. BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells.
Duong HQ; Hwang JS; Kim HJ; Seong YS; Bae I
Int J Oncol; 2012 Dec; 41(6):2227-36. PubMed ID: 23076030
[TBL] [Abstract][Full Text] [Related]
9. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
Ciaglia E; Abate M; Laezza C; Pisanti S; Vitale M; Seneca V; Torelli G; Franceschelli S; Catapano G; Gazzerro P; Bifulco M
Int J Cancer; 2017 Feb; 140(4):959-972. PubMed ID: 27813087
[TBL] [Abstract][Full Text] [Related]
10. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.
Jiang H; Liu W; Zhan SK; Pan YX; Bian LG; Sun B; Sun QF; Pan SJ
PLoS One; 2016; 11(8):e0161017. PubMed ID: 27532105
[TBL] [Abstract][Full Text] [Related]
11. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
Wang N; Zhang Q; Luo L; Ning B; Fang Y
J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
[TBL] [Abstract][Full Text] [Related]
12. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AMPK-associated autophagy enhances caffeic acid phenethyl ester-induced cell death in C6 glioma cells.
Yu SH; Kao YT; Wu JY; Huang SH; Huang ST; Lee CM; Cheng KT; Lin CM
Planta Med; 2011 Jun; 77(9):907-14. PubMed ID: 21243583
[TBL] [Abstract][Full Text] [Related]
14. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
15. Compound C/Dorsomorphin: Its Use and Misuse as an AMPK Inhibitor.
Dasgupta B; Seibel W
Methods Mol Biol; 2018; 1732():195-202. PubMed ID: 29480476
[TBL] [Abstract][Full Text] [Related]
16. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses.
Rao E; Zhang Y; Li Q; Hao J; Egilmez NK; Suttles J; Li B
Oncotarget; 2016 Jun; 7(23):33783-95. PubMed ID: 27177226
[TBL] [Abstract][Full Text] [Related]
17. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells.
Yang WL; Perillo W; Liou D; Marambaud P; Wang P
J Surg Oncol; 2012 Nov; 106(6):680-8. PubMed ID: 22674626
[TBL] [Abstract][Full Text] [Related]
18. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.
Liu X; Chhipa RR; Pooya S; Wortman M; Yachyshin S; Chow LM; Kumar A; Zhou X; Sun Y; Quinn B; McPherson C; Warnick RE; Kendler A; Giri S; Poels J; Norga K; Viollet B; Grabowski GA; Dasgupta B
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):E435-44. PubMed ID: 24474794
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition.
Hartel I; Ronellenfitsch M; Wanka C; Wolking S; Steinbach JP; Rieger J
Int J Oncol; 2016 Jul; 49(1):173-80. PubMed ID: 27121290
[TBL] [Abstract][Full Text] [Related]
20. Kidney bean husk extracts exert antitumor effect by inducing apoptosis involving AMP-activated protein kinase signaling pathway.
Lee YK; Hwang JT; Lee MS; Kim YM; Park OJ
Ann N Y Acad Sci; 2009 Aug; 1171():484-8. PubMed ID: 19723093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
